Fierce Healthcare
JANUARY 9, 2025
Hippocratic AI is kicking off 2025 with a bang. The startup, which is building a large language model specifically for healthcare use cases, banked a $141 million series B financing round only nine months after its series A round.
Pharmacy Times
JANUARY 9, 2025
Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JANUARY 9, 2025
Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.
Drug Topics
JANUARY 9, 2025
Researchers conducted a literature research review to further understand the current evidence regarding diagnosis and treatment for peptic ulcer disease.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JANUARY 9, 2025
Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
Outsourcing Pharma
JANUARY 9, 2025
India's Anthem Biosciences is planning to raise $397m in an initial public offering (IPO).
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JANUARY 9, 2025
Why could we see more deal-making at this year’s J. P. Morgan Healthcare conference? Why are investors concerned about a slowdown in U.S. biotech innovation? And what are the hosts’ New Year’s resolutions? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.
pharmaphorum
JANUARY 9, 2025
A new obesity start-up Verdiva Bio has just decloaked with a whopping $411m to advance a once-weekly oral GLP-1 agonist.
Pharmacy Times
JANUARY 9, 2025
It is important for pharmacists to understand what RSV is, who is most affected by it, and what options are out there to prevent serious disease.
pharmaphorum
JANUARY 9, 2025
GSK is reportedly in negotiations about a $1bn deal to acquire IDRx and its targeted therapy for a form of rare gastrointestinal tumour.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JANUARY 9, 2025
As wildfires ravage Los Angeles County, pharmacists can provide crucial support to their patients.
Pharmacy Times
JANUARY 9, 2025
The late former president played a critical role in advancing cancer care, as well as efforts to eradicate preventable diseases.
Drug Topics
JANUARY 9, 2025
Investigators of a recent study said targeted interventions are needed to reduce the global burden, particularly in developing countries.
pharmaphorum
JANUARY 9, 2025
Grifols has filed for US approval of its new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class launch.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JANUARY 9, 2025
For patients with multiple myeloma who may experience an infection while receiving teclistamab, supplementation with intravenous immunoglobulin (IVIG) can help resolve and prevent serious complications.
The Checkup by Singlecare
JANUARY 9, 2025
Semaglutide is an active ingredient in a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. These prescription drugs are used to treat Type 2 diabetes, promote weight loss , and reduce the risk of heart disease. Common brand-name drugs that contain this ingredient include Ozempic , Wegovy , and Rybelsus all manufactured by Novo Nordisk, a Danish pharmaceutical company.
Pharmacy Times
JANUARY 9, 2025
These new regulatory developments put CUTX-101 on track to become the first FDA-approved treatment for patients with Menkes disease.
Pharmaceutical Technology
JANUARY 9, 2025
Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 9, 2025
Duchenne muscular dystrophy is an incurable neuromuscular disorder that can lead to cardiomyopathy, resulting in heart failure.
Pharmaceutical Technology
JANUARY 9, 2025
Aspect Biosystems has secured $115m in a Series B financing round to advance the development of bioprinted tissue therapeutics.
Pharmacy Times
JANUARY 9, 2025
High-cost medications necessary for treatment require close management to ensure patient safety and to adhere to payer-specific requirements.
Pharmaceutical Technology
JANUARY 9, 2025
The EC has approved the extension of Stallergenes Greers Palforzia for the treatment of peanut allergy in toddlers.
Pharmacy Times
JANUARY 9, 2025
Regulatory action could help patients with Hunter syndrome who have cognitive and behavioral complications and often do not have an effective treatment crossing the blood-brain barrier.
Pharmaceutical Technology
JANUARY 9, 2025
Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
Pharmacy Times
JANUARY 9, 2025
The new designation for the selective PPAR antagonist follows positive phase 1b/2 clinical trial results.
Pharmaceutical Technology
JANUARY 9, 2025
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic disease.
Fierce Healthcare
JANUARY 9, 2025
UnitedHealth Group and Amedisys have asked the courts to dismiss the federal government's challenge to their $3.3 billion merger, arguing that the Department of Justice has not made a clear enough case that it would be anticompetitive.
European Pharmaceutical Review
JANUARY 9, 2025
Three industry bodies have produced a joint position paper highlighting recommendations for adopting a harmonised implementation of electronic Product Information (ePI) leaflets. The electronic Product Information] ePI platform will serve as a single source of trustworthy information, fostering transparency and regulatory efficiency across the EU The pharmaceutical industry associations, European Federation Of Pharmaceutical Industries and Associations (EFPIA), Medicines for Europe and Associati
Fierce Healthcare
JANUARY 9, 2025
A new report from Press Ganey highlights the close relationship between patient experience and health plan star ratings. | A new report from Press Ganey highlights the close relationship between patient experience and health plan star ratings.
DiversifyRx
JANUARY 9, 2025
PBM Optimization remains a critical focus for independent pharmacies. With the majority of pharmacy revenue flowing through Pharmacy Benefit Managers (PBMs), optimizing these claims is essential for maintaining profitability and ensuring compliance. PBM Optimization goes beyond maximizing reimbursement. It should include protecting your earned revenue from audits in addition to ensuring you are compliant with PBM rules and any legal regulations.
Fierce Healthcare
JANUARY 9, 2025
Providers should inform patients in clinical settings about cancer risk, promote alcohol screening and offer treatment referrals, the U.S. surgeon general said in an advisory. Here's how.
Outsourcing Pharma
JANUARY 9, 2025
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an oversubscribed Series A financing round of $411m.
Pharma Marketing Network
JANUARY 9, 2025
Table of Contents Sr# Headings 1 Introduction: Navigating the Pharma Marketing Network 2 Building a Strong Pharma Marketing Network 3 Strategies for Digital Success in Pharma Marketing 4 Leveraging Data and Partnerships for Impact Introduction: Navigating the Pharma Marketing Network The Pharma Marketing Network is more than just a collection of professionalsits a dynamic ecosystem where strategy, creativity, and innovation converge.
Expert insights. Personalized for you.
114 
Let's personalize your content